Vinal Menon1, John F Eberth1,2, Lorain Junor3, Alexander J Potts1, Marwa Belhaj1, Donald J Dipette4, Michael W Jenkins5,6, Jay D Potts1,2. 1. Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina. 2. Biomedical Engineering Program, College of Engineering and Computing, University of South Carolina, Columbia, South Carolina. 3. Instrumentation Resource Facility, University of South Carolina School of Medicine, Columbia, South Carolina. 4. Department of Internal Medicine, University of South Carolina School of Medicine, Columbia, South Carolina. 5. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio. 6. Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio.
Abstract
BACKGROUND: The formation of healthy heart valves throughout embryonic development is dependent on both genetic and epigenetic factors. Hemodynamic stimuli are important epigenetic regulators of valvulogenesis, but the resultant molecular pathways that control valve development are poorly understood. Here we describe how the heart and valves recover from the removal of a partial constriction (banding) of the OFT/ventricle junction (OVJ) that temporarily alters blood flow velocity through the embryonic chicken heart (HH stage 16/17). Recovery is described in terms of 24- and 48-hr gene expression, morphology, and OVJ hemodynamics. RESULTS: Collectively, these studies show that after 24 hr of recovery, important epithelial-mesenchymal transformation (EMT) genes TGFßRIII and Cadherin 11 (CDH11) transcript levels normalize return to control levels, in contrast to Periostin and TGFß,3 which remain altered. In addition, after 48 hr of recovery, TGFß3 and CDH11 transcript levels remain normalized, whereas TGFßRIII and Periostin are down-regulated. Analyses of OFT cushion volumes in the hearts show significant changes, as does the ratio of cushion to cell volume at 24 hr post band removal (PBR). Morphologically, the hearts show visible alteration following band removal when compared to their control age-matched counterparts. CONCLUSIONS: Although some aspects of the genetic/cellular profiles affected by altered hemodynamics seem to be reversed, not all gene expression and cardiac growth normalize following 48 hr of band removal. Developmental Dynamics 247:531-541, 2018.
BACKGROUND: The formation of healthy heart valves throughout embryonic development is dependent on both genetic and epigenetic factors. Hemodynamic stimuli are important epigenetic regulators of valvulogenesis, but the resultant molecular pathways that control valve development are poorly understood. Here we describe how the heart and valves recover from the removal of a partial constriction (banding) of the OFT/ventricle junction (OVJ) that temporarily alters blood flow velocity through the embryonic chicken heart (HH stage 16/17). Recovery is described in terms of 24- and 48-hr gene expression, morphology, and OVJ hemodynamics. RESULTS: Collectively, these studies show that after 24 hr of recovery, important epithelial-mesenchymal transformation (EMT) genes TGFßRIII and Cadherin 11 (CDH11) transcript levels normalize return to control levels, in contrast to Periostin and TGFß,3 which remain altered. In addition, after 48 hr of recovery, TGFß3 and CDH11 transcript levels remain normalized, whereas TGFßRIII and Periostin are down-regulated. Analyses of OFT cushion volumes in the hearts show significant changes, as does the ratio of cushion to cell volume at 24 hr post band removal (PBR). Morphologically, the hearts show visible alteration following band removal when compared to their control age-matched counterparts. CONCLUSIONS: Although some aspects of the genetic/cellular profiles affected by altered hemodynamics seem to be reversed, not all gene expression and cardiac growth normalize following 48 hr of band removal. Developmental Dynamics 247:531-541, 2018.
Authors: Maria Reckova; Carlin Rosengarten; Angela deAlmeida; Chiffvon P Stanley; Andy Wessels; Robert G Gourdie; Robert P Thompson; David Sedmera Journal: Circ Res Date: 2003-05-29 Impact factor: 17.367
Authors: Hong Tan; Stefanie Biechler; Lorain Junor; Michael J Yost; Delphine Dean; Jinqing Li; Jay D Potts; Richard L Goodwin Journal: Dev Biol Date: 2012-12-19 Impact factor: 3.582
Authors: Stefanie V Biechler; Lorain Junor; Ashlie N Evans; John F Eberth; Robert L Price; Jay D Potts; Michael J Yost; Richard L Goodwin Journal: Front Physiol Date: 2014-06-17 Impact factor: 4.566
Authors: Sahar Elahi; Brecken J Blackburn; Maryse Lapierre-Landry; Shi Gu; Andrew M Rollins; Michael W Jenkins Journal: Biomed Opt Express Date: 2020-08-27 Impact factor: 3.732